The suppressive effect of co-inhibiting PD-1 and CTLA-4 expression on H22 hepatomas in mice
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1689-1392
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
The suppressive effect of co-inhibiting PD-1 and CTLA-4 expression on H22 hepatomas in mice ; volume:23 ; number:1 ; day:15 ; month:12 ; year:2018 ; pages:1-11 ; date:12.2018
Cellular & molecular biology letters ; 23, Heft 1 (15.12.2018), 1-11, 12.2018
- Urheber
-
Liang, Leilei
Ge, Keli
Zhang, Fengying
Ge, Yinlin
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s11658-018-0122-0
- URN
-
urn:nbn:de:101:1-2019013123072454598025
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:44 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Liang, Leilei
- Ge, Keli
- Zhang, Fengying
- Ge, Yinlin
- SpringerLink (Online service)
Ähnliche Objekte (12)
RGMB enhances the suppressive activity of the monomeric secreted form of CTLA-4
Dual blockade immunotherapy targeting PD-1/PD-L1 and CTLA-4 in lung cancer
Novel immune checkpoint targets: moving beyond PD-1 and CTLA-4
Combination of CTLA-4 and PD-1 blockers for treatment of cancer
Regulatory mechanisms of immune checkpoints PD-L1 and CTLA-4 in cancer
The CTLA ‐4 immune checkpoint protein regulates PD‐L1: PD ‐1 interaction via transendocytosis of its ligand CD80
Expression of PD-L1, CTLA-4, and LAG-3 in human thyroid carcinoma
MicroRNAs as regulators of immune checkpoints in cancer immunotherapy: targeting PD-1/PD-L1 and CTLA-4 pathways
Neoadjuvant PD-1/PD-L1 combined with CTLA-4 inhibitors for solid malignancies: a systematic review and meta-analysis
rTMS improves dysphagia by inhibiting NLRP3 inflammasome activation and caspase-1 dependent pyroptosis in PD mice
Infusion-Related Reactions Induced by Cadonilimab (PD-1/CTLA-4 Bispecific Antibody): Seven Case Reports
Expression of PD-1 and CTLA-4 Are Negative Prognostic Markers in Renal Cell Carcinoma
RGMB enhances the suppressive activity of the monomeric secreted form of CTLA-4
Dual blockade immunotherapy targeting PD-1/PD-L1 and CTLA-4 in lung cancer
Novel immune checkpoint targets: moving beyond PD-1 and CTLA-4
Combination of CTLA-4 and PD-1 blockers for treatment of cancer
Regulatory mechanisms of immune checkpoints PD-L1 and CTLA-4 in cancer
The CTLA ‐4 immune checkpoint protein regulates PD‐L1: PD ‐1 interaction via transendocytosis of its ligand CD80
Expression of PD-L1, CTLA-4, and LAG-3 in human thyroid carcinoma
MicroRNAs as regulators of immune checkpoints in cancer immunotherapy: targeting PD-1/PD-L1 and CTLA-4 pathways
Neoadjuvant PD-1/PD-L1 combined with CTLA-4 inhibitors for solid malignancies: a systematic review and meta-analysis
rTMS improves dysphagia by inhibiting NLRP3 inflammasome activation and caspase-1 dependent pyroptosis in PD mice
Infusion-Related Reactions Induced by Cadonilimab (PD-1/CTLA-4 Bispecific Antibody): Seven Case Reports
Expression of PD-1 and CTLA-4 Are Negative Prognostic Markers in Renal Cell Carcinoma
RGMB enhances the suppressive activity of the monomeric secreted form of CTLA-4
Dual blockade immunotherapy targeting PD-1/PD-L1 and CTLA-4 in lung cancer
Novel immune checkpoint targets: moving beyond PD-1 and CTLA-4
Combination of CTLA-4 and PD-1 blockers for treatment of cancer
Regulatory mechanisms of immune checkpoints PD-L1 and CTLA-4 in cancer
The CTLA ‐4 immune checkpoint protein regulates PD‐L1: PD ‐1 interaction via transendocytosis of its ligand CD80
Expression of PD-L1, CTLA-4, and LAG-3 in human thyroid carcinoma
MicroRNAs as regulators of immune checkpoints in cancer immunotherapy: targeting PD-1/PD-L1 and CTLA-4 pathways
Neoadjuvant PD-1/PD-L1 combined with CTLA-4 inhibitors for solid malignancies: a systematic review and meta-analysis
rTMS improves dysphagia by inhibiting NLRP3 inflammasome activation and caspase-1 dependent pyroptosis in PD mice
Infusion-Related Reactions Induced by Cadonilimab (PD-1/CTLA-4 Bispecific Antibody): Seven Case Reports